AA
ATRA icon

ALPS Advisors’s Atara Biotherapeutics ATRA Stock Holding History

ALPS Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,827
Closed -$889K – 1035
2022
Q1 		$889K Sell
3,827
-266
-6% -$84.7K 0.01% 322
2021
Q4 		$1.61M Sell
4,093
-62
-1% -$26.1K 0.02% 309
2021
Q3 		$1.86M Sell
4,155
-274
-6% -$98.2K 0.02% 327
2021
Q2 		$1.72M Buy
+4,429
New +$1.58M 0.02% 345
2019
Q2 		– Sell
-4,410
Closed -$4.38M – 881
2019
Q1 		$4.38M Buy
4,410
+190
+5% +$177K 0.03% 178
2018
Q4 		$3.67M Buy
4,220
+1,010
+31% +$938K 0.03% 179
2018
Q3 		$3.32M Buy
3,210
+677
+27% +$662K 0.02% 196
2018
Q2 		$2.33M Buy
2,533
+286
+13% +$307K 0.02% 217
2018
Q1 		$2.19M Buy
2,247
+891
+66% +$812K 0.02% 207
2017
Q4 		$614K Buy
1,356
+152
+13% +$56.1K ﹤0.01% 382
2017
Q3 		$498K Buy
1,204
+153
+15% +$57.7K ﹤0.01% 523
2017
Q2 		$368K Buy
1,051
+58
+6% +$22.3K ﹤0.01% 697
2017
Q1 		$510K Sell
993
-116
-10% -$48K ﹤0.01% 391
2016
Q4 		$394K Sell
1,109
-360
-25% -$152K ﹤0.01% 602
2016
Q3 		$786K Buy
+1,469
New +$798K 0.01% 233
2016
Q1 		– Sell
-1,509
Closed -$996K – 649
2015
Q4 		$996K Sell
1,509
-265
-15% -$200K 0.01% 218
2015
Q3 		$1.39M Buy
1,774
+808
+84% +$985K 0.01% 192
2015
Q2 		$1.27M Buy
+966
New +$1.11M 0.01% 196

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ALPS Advisors's ATRA Position: Q2 2022 in Review

ALPS Advisors sold out of Atara Biotherapeutics (ATRA) in Q2 2022, closing a stake of 3,827 shares — an estimated $889K sold.

ALPS Advisors first reported a position in ATRA in Q2 2015 and held it in 18 quarters. The position peaked at $4.38M in Q1 2019. 134 funds tracked by Wall St. Rank hold ATRA as of Q2 2022.

  • ALPS Advisors reported no remaining Atara Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • ALPS Advisors sold 3,827 Atara Biotherapeutics shares in Q2 2022, an estimated $889K.
  • ALPS Advisors first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 18 quarters.
  • ALPS Advisors's Atara Biotherapeutics position peaked at $4.38M in Q1 2019.
  • 134 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2022.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.